====== Idiopathic intracranial hypertension treatment ======

{{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/10cYQ8mUsB6h5gPhWE01m_cGkvF2JS8_6zBxIXeqTrnUMXjMpB/?limit=15&utm_campaign=pubmed-2&fc=20240227095303}}

[[Idiopathic intracranial hypertension]] (IIH) is still a grey area in the knowledge of the aetiology, diagnosis and management of [[neurosurgical disease]]s.

Most children respond to typical medical treatment such as intravenous carbonic anhydrase or steroids. Indication for surgical treatment include initial severe visual dysfunction or a worsening of the results of a visual test
((Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;9:144–149.)).

At the moment, because the etiology of IIH in children remains unclear, a specific treatment has not yet developed 
((Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri) Horm Res Paediatr. 2010;74:381–389))


Until now there is no [[Level of Evidence 1]] [[guideline]] to which our decision-making can be based on for the management of IIH. A lack of [[systematic review]]s and [[randomized controlled trial]]s has been noted
((Portelli M, Papageorgiou PN. An update on idiopathic intracranial
hypertension. Acta Neurochir (Wien). 2016 Dec 24. doi: 10.1007/s00701-016-3050-7.
[Epub ahead of print] PubMed PMID: 28013373.
)).

Treatment typically consists of weight loss (including [[bariatric surgery]] in morbidly obese patients if needed)
((Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D. Bariatric surgery for
the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011
Jan;114(1):34-9. doi: 10.3171/2009.12.JNS09953. Review. PubMed PMID: 20095788.
)).

===== Idiopathic intracranial hypertension medical treatment =====
[[Idiopathic intracranial hypertension medical treatment]].

===== Medically Refractory Idiopathic Intracranial Hypertension treatment =====
[[Medically Refractory Idiopathic Intracranial Hypertension treatment]].